Skip to content
Search

Latest Stories

LloydsPharmacy Clinical Homecare awarded overall ‘Good’ rating by CQC

LloydsPharmacy Clinical Homecare has been awarded ‘Good’ rating in all five domains- safe, effective, caring, responsive and well-led by the Care Quality Commission (CQC).

This is recognition of the huge turnaround the service has made in such a short space of time. The Harlow site was inspected in October 2022.


Established in 1975, LloydsPharmacy Clinical Homecare is one of the most experienced providers of clinical homecare, and delivers care to more than 100,000 patients in the comfort of their home, at work, or in the community – ranging from straightforward delivery of medication to specialist nursing for complex conditions. The provider was credited with having ‘significantly improved’ following negative feedback from the regulators last year.

In particular, it was reported that ‘all staff were committed to continually learning and improving services. They had a good understanding of quality improvement methods and the skills to use them, and leaders encouraged innovation and participation in research’.

Inspectors highlighted LloydsPharmacy Clinical Homecare’s Remote Nurse Training service, which is for patients with long-term conditions. ‘The service has enabled patients, through telephone training, to self-inject their ongoing treatments. It has facilitated greater independence for patients and has reduced the risk of transmission of the COVID-19 virus to a patient group that were considered vulnerable.’

With a success rate of 99%, the training programme was rolled out nationally across 13 different biological therapies. The service was a finalist in the Nursing Times Awards 2020 in the category of Managing Long-term Conditions.

Nick Davis, CEO of LloydsPharmacy Clinical Homecare, said: “The CQC’s report reflects how far we have come in the last year. Every single person who is part of the LloydsPharmacy Clinical Homecare team - from our front-line nurses and healthcare assistants to our senior management team, has worked extremely hard to bring the service back to a standard that we can be proud of, however, we will not rest on our laurels as we strive to do even better each day.

“We are all dedicated to our programme of continuous improvement, and the regulator’s feedback is extremely important to us. The inspectors have also provided valuable guidance on where we can make even more progress, and it will help us reach our goal of being rated outstanding in the near future.”

 

More For You

MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less